Clinical Trial Update: A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the relative bioavailability of new oral formulations of SRT2104 in healthy male volunteers, with psoriasis listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• SRT2104 (SRT2104)

Snippet

Sponsor: Sirtris, a GSK Company | Conditions: Psoriasis | Phase 1 | Status: COMPLETED